Coagulation abnormalities in acute lung injury and sepsis

[1] Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (01) : L1 - L8

[2] Therapeutic use of antithrombin concentrate in sepsis [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 (02) : 183 - 194

[3] DEPRESSED BRONCHOALVEOLAR UROKINASE ACTIVITY IN PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROME [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (13) : 890 - 897

[4] BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223

[5] PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J]. CLINICAL SCIENCE, 1995, 88 (05) : 587 - 594

[6] Blackwell TS, 1996, J IMMUNOL, V157, P1630

[7] EFFECTS OF OXIDANTS AND ANTIOXIDANTS ON NUCLEAR FACTOR KAPPA-B ACTIVATION IN 3 DIFFERENT CELL-LINES - EVIDENCE AGAINST A UNIVERSAL HYPOTHESIS INVOLVING OXYGEN RADICALS [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1260 (02): : 167 - 175

[8] BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90

[9] Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) : 668 - 676

[10] TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) : 2850 - 2860

[1] Effects of endogenous and exogenous catecholamines on LPS-induced neutrophil trafficking and activation [J]. AMERICAN JOURNAL OF PHYSIOLOGY-LUNG CELLULAR AND MOLECULAR PHYSIOLOGY, 1999, 276 (01) : L1 - L8

[2] Therapeutic use of antithrombin concentrate in sepsis [J]. SEMINARS IN THROMBOSIS AND HEMOSTASIS, 1998, 24 (02) : 183 - 194

[3] DEPRESSED BRONCHOALVEOLAR UROKINASE ACTIVITY IN PATIENTS WITH ADULT RESPIRATORY-DISTRESS SYNDROME [J]. NEW ENGLAND JOURNAL OF MEDICINE, 1990, 322 (13) : 890 - 897

[4] BIEMOND BJ, 1995, THROMB HAEMOSTASIS, V73, P223

[5] PLASMINOGEN-ACTIVATOR AND PLASMINOGEN-ACTIVATOR INHIBITOR-1 RELEASE DURING EXPERIMENTAL ENDOTOXEMIA IN CHIMPANZEES - EFFECT OF INTERVENTIONS IN THE CYTOKINE AND COAGULATION CASCADES [J]. CLINICAL SCIENCE, 1995, 88 (05) : 587 - 594

[6] Blackwell TS, 1996, J IMMUNOL, V157, P1630

[7] EFFECTS OF OXIDANTS AND ANTIOXIDANTS ON NUCLEAR FACTOR KAPPA-B ACTIVATION IN 3 DIFFERENT CELL-LINES - EVIDENCE AGAINST A UNIVERSAL HYPOTHESIS INVOLVING OXYGEN RADICALS [J]. BIOCHIMICA ET BIOPHYSICA ACTA-GENE STRUCTURE AND EXPRESSION, 1995, 1260 (02): : 167 - 175

[8] BROZE GJ, 1995, THROMB HAEMOSTASIS, V74, P90

[9] Delayed treatment with recombinant human tissue factor pathway inhibitor improves survival in rabbits with gram-negative peritonitis [J]. JOURNAL OF INFECTIOUS DISEASES, 1998, 177 (03) : 668 - 676

[10] TISSUE FACTOR PATHWAY INHIBITOR REDUCES MORTALITY FROM ESCHERICHIA-COLI SEPTIC SHOCK [J]. JOURNAL OF CLINICAL INVESTIGATION, 1993, 91 (06) : 2850 - 2860